ROCA, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 4.946
AS - Asia 2.151
EU - Europa 1.524
SA - Sud America 482
AF - Africa 36
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.150
Nazione #
US - Stati Uniti d'America 4.882
CN - Cina 738
SG - Singapore 738
BR - Brasile 401
UA - Ucraina 376
DE - Germania 334
HK - Hong Kong 273
VN - Vietnam 170
IT - Italia 142
GB - Regno Unito 129
RU - Federazione Russa 128
FI - Finlandia 101
TR - Turchia 85
IE - Irlanda 76
PL - Polonia 65
FR - Francia 43
CA - Canada 40
CZ - Repubblica Ceca 36
AR - Argentina 35
IN - India 31
BD - Bangladesh 28
BE - Belgio 19
SE - Svezia 19
IQ - Iraq 18
JP - Giappone 15
EC - Ecuador 13
MX - Messico 13
NL - Olanda 13
ES - Italia 12
CO - Colombia 10
ZA - Sudafrica 10
AT - Austria 9
SA - Arabia Saudita 9
VE - Venezuela 9
AU - Australia 6
DZ - Algeria 6
ID - Indonesia 6
PY - Paraguay 6
IR - Iran 5
MA - Marocco 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
EG - Egitto 4
EU - Europa 4
JM - Giamaica 4
LT - Lituania 4
CL - Cile 3
NP - Nepal 3
RO - Romania 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
PK - Pakistan 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 9.150
Città #
Fairfield 755
Ashburn 431
Woodbridge 391
Singapore 336
Jacksonville 316
Houston 310
Seattle 290
Hong Kong 270
Cambridge 257
Wilmington 248
Beijing 204
Chandler 202
Ann Arbor 179
Princeton 146
New York 110
Nanjing 102
Helsinki 79
The Dalles 77
Dublin 76
Los Angeles 76
Istanbul 69
Dearborn 64
Warsaw 63
Munich 55
Ho Chi Minh City 52
Des Moines 41
Dallas 40
Nanchang 36
Changsha 35
São Paulo 34
Moscow 33
Hanoi 31
Chicago 30
Hebei 29
San Diego 29
Brescia 28
Shanghai 28
Redondo Beach 27
San Francisco 26
Shenyang 25
Buffalo 24
Brno 22
London 21
Boardman 19
Brussels 19
Jinan 19
Turku 19
San Mateo 18
Atlanta 16
Montreal 16
Tianjin 16
Denver 14
Olomouc 14
Toronto 14
Brooklyn 13
Tokyo 13
Zhengzhou 13
Boston 12
Jiaxing 12
Nürnberg 12
Orem 12
Kunming 11
Santa Clara 11
Stockholm 11
Belo Horizonte 10
Dhaka 10
Dong Ket 10
Poplar 10
Rio de Janeiro 10
Falls Church 8
Guangzhou 8
Hangzhou 8
Lanzhou 8
Ningbo 8
Taizhou 8
Washington 8
Augusta 7
Chennai 7
Da Nang 7
Milan 7
Nuremberg 7
Betim 6
Biên Hòa 6
Campinas 6
Charlotte 6
Council Bluffs 6
Haiphong 6
Jeddah 6
Kilburn 6
Lancaster 6
Manaus 6
Napoli 6
Amsterdam 5
Ardabil 5
Frankfurt am Main 5
Haikou 5
Hefei 5
Manchester 5
Mexico City 5
Pelotas 5
Totale 6.248
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 232
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 201
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 195
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 194
Acute functional reactivation of the language network during awake intraoperative brain mapping 189
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 186
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 182
Regression of advanced neuroendocrine tumors among patients receiving placebo 179
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 178
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 178
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 177
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 175
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 173
Palbociclib inhibits proliferation of human adrenocortical tumor cells 171
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 170
Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders 168
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 167
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 163
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 162
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 161
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 160
Serum vitamin D and prostate cancer prognosis: The story continues 157
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 156
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 156
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 155
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 154
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 153
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 146
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 145
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 142
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 141
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 140
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: Prediction of the response to the first-line chemotherapy 139
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 139
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 138
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 136
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 134
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies 133
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study 133
Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer 131
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology 126
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 123
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma 116
CT scanner for the pleural staging of pleural cancer: How accurate is this? 116
Malignant pleural mesothelioma: from the bench to the bedside 115
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 112
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? 110
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 109
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 103
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough 102
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions 101
False Negative Pleural Cytology in Patient with Malignant Pleurisies: Is Pleural EpCAM-Positive Microparticles a Complementary Tool for Diagnosis? 101
Malignant pleural mesothelioma signs and symptoms 100
CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer 98
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort 94
Onde elettromagnetiche ad alta frequenza e bassa intensit. nel trattamento delle ulcere cutanee: 8 casi clinici. 90
THE ASSOCIATION BETWEEN PROTEOMIC PROFILE DETECTED BEFORE 2ND/3RD LINE EGFR-TKIS AND RESPONSE TO 1ST LINE CHEMOTHERAPY 89
Pathologie pleurale 85
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER 82
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice 66
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 62
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration 61
Onde elettromagnetiche ad alta frequenza e bassa intensità nel trattamento delle ulcere cutanee: 8 casi clinici 61
Thoracic Cytological Specimens Obtained In Routine Clinical Practice And EGFR, Kras, Her2, Braf And Pi3kca Mutation Status In Metastatic Cancer Patients 60
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity 59
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation 59
Maintenance with Lanreotide in SCLC Patients, Expressing Somatostatine Receptors, after Response to First Line Therapy 58
PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS 58
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 56
Multigene Mutation Analysis Of Mediastinal Lymph Nodes Assessed By Endobronchial Ultrasound-Guided Needle Aspiration: A Prospective Study 55
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 55
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 55
Is DNA repair a potential target for effective therapies against malignant mesothelioma? 43
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 38
Totale 9.307
Categoria #
all - tutte 44.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021794 0 0 0 0 0 115 47 134 110 164 156 68
2021/2022592 38 66 33 45 9 36 21 63 25 72 47 137
2022/2023589 85 24 16 44 53 130 3 74 105 1 24 30
2023/2024618 47 22 63 34 33 91 19 21 154 9 6 119
2024/20251.323 20 5 8 199 145 93 117 53 183 74 259 167
2025/20261.825 262 440 240 426 321 136 0 0 0 0 0 0
Totale 9.307